EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comment on the Article “Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study”

Chi Xu, Jiapeng Sun, Qiongyu Liang, Kang Zhou, Jie Pan

Liver Cancer · 14.11.2026

DOI: 10.1159/lic/admag028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver Cancer, online erschienen am 14.11.2026. Verfasst von Chi Xu und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Xu, C., Sun, J., Liang, Q., Zhou, K., & Pan, J. (2026). Comment on the Article “Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study”. Liver Cancer. https://doi.org/10.1159/lic/admag028

Vancouver

Xu C, Sun J, Liang Q, Zhou K, Pan J. Comment on the Article “Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study”. Liver Cancer. 2026. doi:10.1159/lic/admag028

BibTeX
@article{Xu2026,
  author = {Xu, Chi and Sun, Jiapeng and Liang, Qiongyu and Zhou, Kang and Pan, Jie},
  title = {Comment on the Article “Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study”},
  journal = {Liver Cancer},
  year = {2026},
  doi = {10.1159/lic/admag028}
}
Kostenlos starten →